OMB APPROVAL
OMB Number: 3235-0058
Expires: May 31, 1997
Estimated average burden
hours per response....2.50
__________________________
SEC FILE NUMBER
__________________________
CUSIP NUMBER
__________________________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K
[ ] Form 10-Q [ ] Form N-SAR CUSIP NUMBER
For Period Ended: 12/31/96
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: ______________________
_________________________________________________________________
Read Instruction (on back page) Before Preparing Form.
Please Print or Type.
Nothing in this form shall be construed to imply that the
Commission has verified any information contained herein.
_________________________________________________________________
If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
_________________________________________________________________
PART I - REGISTRANT INFORMATION
Advanced Medical, Inc.
_________________________________________________________________
Full Name of Registrant
_________________________________________________________________
Former Name if Applicable
10221 Wateridge Circle
_________________________________________________________________
Address of Principal Executive Office (Street and Number)
San Diego, CA 92121
_________________________________________________________________
City, State and Zip Code
<PAGE>
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to
Rule 12b-25(b), the following should be completed. (Check box if
appropriate)
[X] (a) The reasons described in reasonable detail in Part III
of this form could not be eliminated without
unreasonable effort or expense;
[ ] (b) The subject annual report, semi-annual report,
transition report on Form 10-K, Form 20-F, 11-K or Form
N-SAR, or portion thereof, will be filed on or before
the fifteenth calendar day following the prescribed due
date; or the subject quarterly report of transition
report on Form 10-Q, or portion thereof will be filed
on or before the fifth calendar day following the
prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed
within the prescribed time period.
On November 26, 1996, Advanced Medical, Inc. (the
"Company"), through a wholly-owned subsidiary completed a major
acquisition. In connection with the acquisition, the Company
terminated certain of its indebtedness and incurred certain other
indebtedness. As a result of such transactions, it was necessary
for the Company to complete an analysis of (i) the allocation of
the purchase price for the assets acquired and liabilities
assumed with respect to the acquisition, (ii) the consolidation
of the results of operations of the entity acquired by the
Company along with those of the Company and (iii) the effects of
the termination of certain indebtedness and the incurrence of
other indebtedness. Such analysis created a delay in the
preparation of the Company's financial statements, which delay
could not be avoided or eliminated without unreasonable effort or
expense.
(Attach Extra Sheets if Needed)
SEC 1344 (6/94)
<PAGE>
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to
this notification
Robert Matthews (619) 458-7000
________________________ ___________ __________________
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or
15(d) of the Securities Exchange Act of 1934 or Section 30
of the Investment Company Act of 1940 during the preceding
12 months or for such shorter period that the registrant was
required to file such report(s) been filed? If answer is
no, identify report(s). [X] Yes [ ] No
_________________________________________________________________
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal
year will be reflected by the earnings statements to be
included in the subject report or portion thereof?
[X] Yes [ ] No
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state
the reasons why a reasonable estimate of the results cannot
be made.
The Company's results of operations for the year ended
December 31, 1996, will differ significantly from the results of
operations for the prior year. This change arises from (i) the
allocation of the purchase price for the assets acquired and
liabilities assumed with respect to the acquisition, (ii) the
consolidation of the results of operations of the entity acquired
by the Company along with those of the Company and (iii) the
effects of the termination of certain indebtedness and the
incurrence of other indebtedness by the Company. At the time of
this filing, the effects on the Company's results of operations
had not yet been finalized.
_________________________________________________________________
Advanced Medical, Inc.
_______________________________________________________
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
4/1/97 /s/William J. Mercer
Date _____________________ By _______________________________
INSTRUCTION: The form may be signed by an executive officer of
the registrant or by any other duly authorized representative.
The name and title of the person signing the form shall be typed
or printed beneath the signature. If the statement is signed on
behalf of the registrant by an authorized representative (other
than an executive officer), evidence of the representative's
authority to sign on behalf of the registrant shall be filed with
the form.
- - -------------------------ATTENTION-------------------------------
Intentional misstatements or omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001).
_________________________________________________________________
<PAGE>
GENERAL INSTRUCTIONS
1. This form is required by Rule 12b-25 (17 CFR 240.12b-25) of
the General Rules and Regulations under the Securities
Exchange ct of 1934.
2. One signed original and four conformed copies of this form
and amendments thereto must be completed and filed with the
Securities and Exchange Commission, Washington, D.C. 20549,
in accordance with Rule 0-3 of the General Rules and
Regulations under the Act. The information contained in or
filed with the form will be made a matter of public record
in the Commission files.
3. A manually signed copy of the form and amendments thereto
shall be filed with each national securities exchange on
which any class of securities of the registrant is
registered.
4. Amendments to the notifications must also be filed on form
12b-25 but need not restate information that has been
correctly furnished. The form shall be clearly identified
as an amended notification.
5. Electronic Filers. This form shall not be used by
electronic filers unable to timely file a report solely due
to electronic difficulties. Filers unable to submit a
report within the time period prescribed due to difficulties
in electronic filing should comply with either Rule 201 or
Rule 202 of Regulation S-T (Section 232.201 or Section
232.202 of this chapter) or apply for an adjustment in
filing date pursuant to Rule 13(b) of Regulation S-T
(Section 232.13(b) of this chapter).
